New Market Study, "Lithuania Pharmaceuticals & Healthcare Report Q1 2014", Has Been Published
BMI View: We expect the Lithuanian pharmaceutical market to post a five-year compound annual growth rate (CAGR) of 4.0%, rising to a value of LTL2.09bn (US$726mn) in 2017. While double-digit annual growth rates are firmly in the past, some opportunities continue to exist in light of epidemiological factors and an ageing population. However, finances will remain tight, both in terms of public and private spending on medicines and healthcare in general.
View full press release